骨折联络服务的成本效果分析:基于荷兰真实世界数据的马尔可夫模型
本研究从社会视角评估荷兰骨折联络服务(FLS)相较于无FLS的终身成本效果。针对近期骨折的50岁及以上患者,FLS与终身成本增加45欧元及额外获得0.11个质量调整生命年(QALY)相关,增量成本效果比(ICER)为每获得1个QALY需409欧元,低于荷兰20000欧元/QALY的阈值,提示FLS具有成本效果。
要点
- FLS与无FLS相比,ICER为每QALY 409欧元,低于荷兰20000欧元/QALY阈值。
- 概率敏感性分析显示FLS在90%的模拟中具有成本效果(女性92% vs 男性84%)。
- FLS的治疗启动率越高,其成本效果越好。
核心结论
- 本研究提供了荷兰首个FLS的健康经济学分析,提示实施FLS可带来终身健康经济获益。
研究设计与样本
- 研究从社会视角,基于荷兰一家大型二级护理医院2017-2019年的年度骨折发生率、治疗方案及治疗启动情况,构建个体水平的状态转换模型模拟终身成本和QALY。
- 治疗路径按性别、骨质疏松和/或现存椎体骨折的存在与否以及治疗状态进行区分。
- 研究进行了单因素和概率敏感性分析。
主要发现
- 对于近期骨折的50岁及以上患者,存在FLS与终身成本增加45欧元及额外获得0.11个QALY相关,导致ICER为每获得1个QALY需409欧元。
- FLS在不同年龄类别中均保持成本效果。
- 单因素敏感性分析中结果稳健,FLS的治疗启动率越高,FLS的成本效果越好。
- 概率敏感性分析显示,在20000欧元/QALY阈值下,FLS在90%的模拟中具有成本效果,按性别分女性为92% vs 男性为84%。
关键数值与推荐
- FLS相较于无FLS的ICER为每获得1个QALY需409欧元,低于荷兰20000欧元/QALY的阈值。
- 概率敏感性分析中FLS具有成本效果的模拟比例为90%,女性92% vs 男性84%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: This study assessed the lifetime cost-effectiveness of a fracture liaison service (FLS) compared to no-FLS in the Netherlands from a societal perspective and suggested that FLS was cost-effective in patients with a recent fracture aged 50 years and older. The implementation of FLS could lead to lifetime health-economic benefits. INTRODUCTION: The objective of this study was to investigate the lifetime cost-effectiveness of a fracture liaison service (FLS) compared to no-FLS in the Netherlands from a societal perspective and using real-world data. METHODS: Annual fracture incidence, treatment scenarios as well as treatment initiation in the years 2017-2019 were collected from a large secondary care hospital in the Netherlands. An individual-level, state transition model was designed to simulate lifetime costs and quality-adjusted life years (QALYs). Treatment pathways were differentiated by gender, presence of osteoporosis and/or prevalent vertebral fracture, and treatment status. Results were presented as incremental cost-effectiveness ratios (ICER). Both one-way and probabilistic sensitivity analyses were conducted. RESULTS: For patients with a recent fracture aged 50 years and older, the presence of an FLS was associated with a lifetime €45 higher cost and 0.11 additional QALY gained leading to an ICER of €409 per QALY gained, indicating FLS was cost-effective compared to no-FLS at the Dutch threshold of €20,000/QALY. The FLS remained cost-effectiveness across different age categories. Our findings were robust in all one-way sensitivity analyses, the higher the treatment initiation rate in FLS, the greater the cost-effective of FLS. Probabilistic sensitivity analyses revealed that FLS was cost-effective in 90% of the simulations at the threshold of €20,000/QALY, with women 92% versus men 84% by gender. CONCLUSION: This study provides the first health-economic analysis of FLS in the Netherlands, suggesting the implementation of FLS could lead to lifetime health-economic benefits.
引用
- Li N, van den Bergh JP, Boonen A, et al. Cost-effectiveness analysis of fracture liaison services: a Markov model using Dutch real-world data. Osteoporos Int. 2023. PMID: 37783759. doi:10.1007/s00198-023-06924-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。